Research - Ness Ziyyona, Center District, Israel
ApoRx is a drug discovery company focusing on the discovery, design, characterization, and development of small proteolysis targeting molecules (PTMs) against well-validated disease-causing proteins in cancer and other indications.Our technology is based on a proprietary focus library of RING E3 ligase binders and is designed to harness the intracellular Ubiquitin-Proteasome machinery to degrade and destroy unwanted proteins by Targeted Protein Degradation.
Gmail
Varnish
Wix
Mobile Friendly
Google Cloud Hosting